Share-Based Compensation |
Share-Based Compensation The following tables summarize the activity during the period under the Company's 2014 Amended and Restated Stock Incentive Plan (the "2014 Plan") and 2021 Equity Incentive Plan (the "2021 Plan").
Restricted Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares |
|
Weighted average grant date fair value |
|
|
|
|
Unvested at December 31, 2023 |
529,862 |
|
|
$ |
11.42 |
|
Granted |
88,499 |
|
|
9.09 |
|
Vested |
(67,844) |
|
|
17.44 |
|
Vested shares forgone to satisfy minimum statutory withholding |
(38,656) |
|
|
17.44 |
|
Forfeitures |
(3,500) |
|
|
13.25 |
|
Unvested at March 31, 2024 |
508,361 |
|
|
$ |
9.74 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2024 |
|
2023 |
|
|
|
|
|
|
0 |
|
|
|
|
|
Weighted average grant date fair value of awards granted |
$ |
9.09 |
|
|
$ |
— |
|
|
|
|
|
Total fair value of shares vested |
$ |
641,823 |
|
|
$ |
273,994 |
|
|
|
|
|
Total fair value of shares forgone to satisfy minimum statutory withholding |
$ |
365,697 |
|
|
$ |
167,251 |
|
|
|
|
|
Performance-Based Restricted Stock Units ("PSU")
For the three months ended March 31, 2024, there were no grants, vesting, or forfeitures of PSUs.
Stock Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014 Plan (Options) |
|
Number of Authorized Shares |
|
Weighted- Average Exercise Price |
|
Weighted- Average Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |
|
657,346 |
|
|
$ |
6.69 |
|
|
4.16 |
|
$ |
2,983,514 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeitures and expirations |
|
(500) |
|
|
18.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2024 |
|
656,846 |
|
|
$ |
6.68 |
|
|
3.91 |
|
$ |
2,099,944 |
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2024 |
|
656,846 |
|
|
$ |
6.68 |
|
|
3.91 |
|
$ |
2,099,944 |
|
Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 Plan (Options) |
|
Number of Authorized Shares |
|
Weighted- Average Exercise Price |
|
Weighted- Average Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |
|
1,051,673 |
|
|
$ |
11.05 |
|
|
8.79 |
|
$ |
1,207,118 |
|
Granted |
|
152,927 |
|
|
8.97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeitures and expirations |
|
(31,291) |
|
|
9.73 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2024 (a) |
|
1,173,309 |
|
|
$ |
10.81 |
|
|
8.71 |
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2024 (a) |
|
309,597 |
|
|
$ |
14.31 |
|
|
7.60 |
|
$ |
— |
|
(a) Aggregate Intrinsic Value - no exercisable options were in-the-money as of March 31, 2024
Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.
The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Stock Options: |
|
2024 |
|
|
|
|
|
|
Expected volatility |
|
50% to 51% |
|
|
|
|
|
|
Risk free interest rate |
|
4.25% to 4.28% |
|
|
|
|
|
|
Expected lives at date of grant (in years) |
|
4.06 |
|
|
|
|
|
|
Weighted average fair value of options granted |
|
$3.97 |
|
|
|
|
|
|
Total intrinsic value of options exercised |
|
$ |
— |
|
|
|
|
|
|
|
For the three months ended March 31, 2023, the Company did not grant any options, and thus that time period is excluded from the table above.
|